Advocacy Actions
Lobby Letter to NPC LAC on China Standardlization Law Revision
On 15th September, SCAWG and QSWG submitted lobby letter to NPC Law Affairs Committee on the China Standardization Law Revision.
Read moreLobby Letter to AQSIQ
On 15th September, the SCA WG submitted a lobby letter to AQSIQ regarding the implication of its released Announcement on <Valid Normative Documents and Abolishment of Some Normative Documents> in July 2014. This is a joint lobby action among USITO, EUCCC, ECFIC and JEITA. This letter expresses European Industry's position on administrative simplification,and also concerns over potential liability in relation to regulation abolishment, such as labeling specification and other affected technical requirements. The purpose of this letter is to get clarification from AQSIQ.
Read moreMeeting with PCPC – Getting in touch
This was the first face-to-face meeting among EUCCC Cosmetic Working Group (after Cocoa joined the EUCCC), Amcham and PCPC. All parties gave each other a brief introduction of its current working priorities. The discussion was mainly about cooperation of three parties on the industrial general concerns, such as CHMR revision. All parties shared information and agreed to work even closer on this area.
Read moreCall for Comments on TC260 ( Information Security Standard Committee )
Based on the input from the ICT&SCA Working Group members, the European Chamber provided comments to TC260(Information Security Standard Committee) on the draft of Industrial control system terminal security requirements.
International Symposium on Infant Food Safety and Development
The International Symposium discussed about the updates and overview of Chinese regulations on infant food safety and the SPIFAN project. The PN Desk helped with inviting key speakers for the symposium.
Read moreCAFFCI Annual Meeting
CAFFCI organised its annual conference and 30 year anniversary in Hangzhou. In the High-level Management Summit, executives from seven companies hosted a panel discussion along with more than 80 participants to discuss the relationship of government regulation and industrial self-disciplinary. Mr. Qi Liubin attended and chaired this session.
Read moreSubmit Comments to CFDA on Medical Device Supervision
Submit Comments to CFDA on Medical Device Supervision
Read moreA briefing on Clinical Trial Requirements / Clinical Evaluation for upcoming IMDRF meeting and JCCT meeting
A briefing on Clinical Trial Requirements / Clinical Evaluation for upcoming IMDRF meeting and JCCT meeting
Read moreLobby Letter to China CFDA – Missing Ingredients
On 10 September 2014, the Cosmetic Working Group submitted a thanks letter to the China Food and Drug Administration to appreciate their written response on our previous report regarding the suspicious missing ingredients based on the published 8783 version used ingredients list, and raise another industrial concern to the registration department.
Read moreMeeting with DG WTO Affairs, MOFCOM
On September 3rd, European Chamber representatives led by Vice President Sara Marchetta met with Madame Zhao Hong, Director General and Chief WTO Negotiator of MOFCOM’s WTO Affairs Department.